Zhitong Finance learned that, according to informed sources cited by the media, hedge fund Glenview Capital Management will meet with executives of CVS Health (CVS.US) on Monday to propose improvements in operations. At the time of this meeting, Glenview, led by founder Larry Robbins, has invested approximately $0.7 billion in CVS Health, which is a significant portion of his $2.5 billion hedge fund. Currently, Glenview holds about 1% of CVS Health's outstanding shares. CVS Health has a market cap of $77.2 billion.

The report cited informed sources as saying that Glenview's holdings indicate Robbins' confidence in the company's potential, and he believes he can lead executives down a new path. The discussion is expected to focus on strengthening the global strategy of CVS Health operations, especially considering recent challenges, including multiple profit downgrades throughout the year.

Previously, CVS Health lowered its full-year profit expectations, citing pressure on the medical benefits department of its insurance subsidiary, Aetna. The healthcare giant has reduced its annual profit outlook to between $6.40 and $6.65 per share (market consensus at $6.54 per share). CVS Health's stock price has fallen by about 23% since the beginning of this year.